Patent · US Active

Benzazepine derivatives

US10889570B2 · kind B2 · utility

0Cited by
6References
58Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2018
Grant dateJan 12, 2021
Priority date
Expiry dateJun 29, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D223/16
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides novel benzazepine compounds of Formula (1), or salts thereof, having vasopressin V1a and V2 antagonisms, and medical uses thereof.In the formula, R1 is optionally substituted C1-6 alkyl, etc.; L is —C(═O)—NH—, etc.; Ring A1 is a hydrocarbon ring, etc.; Ring A2 is a hydrocarbon ring, etc.; and each of Rings A1 and A2 may have at least one substituent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.